1. Home
  2. ACET vs FRD Comparison

ACET vs FRD Comparison

Compare ACET & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$6.50

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Logo Friedman Industries Inc.

FRD

Friedman Industries Inc.

HOLD

Current Price

$17.62

Market Cap

134.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
FRD
Founded
1947
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
134.3M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
ACET
FRD
Price
$6.50
$17.62
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$48.33
N/A
AVG Volume (30 Days)
86.5K
24.7K
Earning Date
03-12-2026
02-09-2026
Dividend Yield
N/A
0.89%
EPS Growth
N/A
N/A
EPS
N/A
1.46
Revenue
N/A
$121,157,278.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.34
Revenue Growth
N/A
55.82
52 Week Low
$0.45
$12.24
52 Week High
$9.05
$24.37

Technical Indicators

Market Signals
Indicator
ACET
FRD
Relative Strength Index (RSI) 39.36 44.76
Support Level $0.64 $16.26
Resistance Level $8.34 $22.82
Average True Range (ATR) 0.39 0.90
MACD -0.08 0.11
Stochastic Oscillator 3.82 51.49

Price Performance

Historical Comparison
ACET
FRD

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

Share on Social Networks: